GlucoTrack, Inc.GlucoTrack, Inc.GlucoTrack, Inc.

GlucoTrack, Inc.

No trades
See on Supercharts
Market capitalization
‪24.11 M‬USD
−0.3497USD
‪−7.10 M‬USD
‪20.93 M‬
Beta (1Y)
−2.37

About GlucoTrack, Inc.

CEO
Paul V. Goode
Headquarters
Rutherford
Employees (FY)
6
Founded
2001
FIGI
BBG0025SKQ53
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GCTK is 0.7600 USD — it has decreased by 15.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GlucoTrack, Inc. stocks are traded under the ticker GCTK.
GCTK stock is 26.50% volatile and has beta coefficient of −2.37. Check out the list of the most volatile stocks — is GlucoTrack, Inc. there?
Yes, you can track GlucoTrack, Inc. financials in yearly and quarterly reports right on TradingView.
GCTK stock has risen by 80.95% compared to the previous week, the month change is a 127.14% rise, over the last year GlucoTrack, Inc. has showed a 15.13% increase.
GCTK net income for the last quarter is ‪−2.41 M‬ USD, while the quarter before that showed ‪−2.22 M‬ USD of net income which accounts for −8.50% change. Track more GlucoTrack, Inc. financial stats to get the full picture.
Today GlucoTrack, Inc. has the market capitalization of ‪24.11 M‬, it has increased by 11.75% over the last week.
No, GCTK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GCTK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlucoTrack, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GCTK reached its all-time high on Jul 22, 2013 with the price of 130.0000 USD, and its all-time low was 0.1328 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 6.00 employees. See our rating of the largest employees — is GlucoTrack, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlucoTrack, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlucoTrack, Inc. stock shows the neutral signal. See more of GlucoTrack, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.